Kala Bio Inc Sustainability Reports
KALA BIO, Inc. is a biopharmaceutical company operating under a dual\-growth strategy that combines a proprietary biologics drug pipeline with an enterprise artificial intelligence platform. The company researches and develops mesenchymal stem cell secretome \(MSC\-S\) therapies for rare and severe diseases of the eye, while simultaneously deploying its Researgency.ai platform to provide secure, agentic AI infrastructure for biotechnology and pharmaceutical research. \(https://finance.yahoo.com/quote/KALA/profile/\) [0] [1] [2]
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900Y7RO0C9P0TX474
2 reports from 2022 to 2023
